Login / Signup
You Won Lee
(You-Won Lee)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 5
Top Topics
Advanced Non Small Cell Lung Cancer
Anti Inflammatory
Epidermal Growth Factor Receptor
Cerebral Ischemia
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Yonsei medical journal
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Eun Ji Lee
,
Seung Yeon Oh
,
You Won Lee
,
Ju Young Kim
,
Min-Je Kim
,
Tae Ho Kim
,
Jii Bum Lee
,
Min Hee Hong
,
Sun Min Lim
,
Anke Baum
,
Lydia Woelflingseder
,
Harald Engelhardt
,
Mark Petronczki
,
Flavio Solca
,
Mi Ran Yun
,
Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Eun Ji Lee
,
Seung Yeon Oh
,
You Won Lee
,
Ju Young Kim
,
Min-Je Kim
,
Tae Ho Kim
,
Jii Bum Lee
,
Min Hee Hong
,
Sun Min Lim
,
Anke Baum
,
Lydia Woelflingseder
,
Harald Engelhardt
,
Mark Petronczki
,
Flavio Solca
,
Mi Ran Yun
,
Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (8) (2024)
Eun Ji Lee
,
Seung Yeon Oh
,
You Won Lee
,
Ju Young Kim
,
Min-Je Kim
,
Tae Ho Kim
,
Jii Bum Lee
,
Min Hee Hong
,
Sun Min Lim
,
Anke Baum
,
Lydia Woelflingseder
,
Harald Engelhardt
,
Mark Petronczki
,
Flavio Solca
,
Mi Ran Yun
,
Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (8) (2024)
Seung Yeon Oh
,
You Won Lee
,
Eun Ji Lee
,
Seok-Young Kim
,
Young Joon Park
,
Seong Gu Heo
,
Mi Ra Yu
,
Min Hee Hong
,
John O DaSilva
,
Christopher Daly
,
Byoung Chul Cho
,
Sun Min Lim
,
Mi Ran Yun
Preclinical study of a biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2022)
Chun-Bong Synn
,
Dong Kwon Kim
,
Seok-Young Kim
,
Youngseon Byeon
,
Young Seob Kim
,
Mi Ran Yun
,
Ji Min Lee
,
Wongeun Lee
,
Eun Ji Lee
,
Seul Lee
,
You Won Lee
,
Doo Jae Lee
,
Hyun-Woo Kim
,
Chang Gon Kim
,
Min Hee Hong
,
June Dong Park
,
Sun Min Lim
,
Kyoung-Ho Pyo
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor.
Yonsei medical journal
63 (1) (2021)